Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (161-170 of 917) with videos related to

Pageof 92
Sort By:
JAMA Oncology|November 20, 2018
Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of MortalityDerya Tilki, Ming-Hui Chen, Jing Wu, et al.
European Urology Focus|November 21, 2017
Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European InstitutionsGiorgio Gandaglia, Derya Tilki, Emanuele Zaffuto, et al.
World Journal of Urology|March 28, 2018
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomyDerya Tilki, Felix Preisser, Pierre Karakiewicz, et al.
World Journal of Urology|April 11, 2015
Controversial evidence for the use of HistoScanning™ in the detection of prostate cancerJonas Schiffmann, Lukas Manka, Katharina Boehm, et al.
European Urology|April 19, 2017
Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation TherapyPrasanna Sooriakumaran, Tommy Nyberg, Olof Akre, et al.
Health and Quality of Life Outcomes|February 26, 2021
Health-related quality of life and self-reported cognitive function in patients with delayed neurocognitive recovery after radical prostatectomy: a prospective follow-up studyUrsula Kahl, Sarah Callsen, Stefanie Beck, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancerDirk Rades, Rudolf Schwarz, Manuel Todorovic, et al.
World Journal of Urology|January 14, 2016
Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomyBurkhard Beyer, Philipp Mandel, Uwe Michl, et al.
Asian Journal of Urology|February 5, 2024
Prevention of thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to a factor V Leiden mutation by multidisciplinary coagulation managementRandi M Pose, Sophie Knipper, Jonas Ekrutt, et al.
The Journal of Urology|March 2, 2016
Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical ProstatectomyKatharina Boehm, Alessandro Larcher, Zhe Tian, et al.
Pageof 92

Showing results (161-170 of 917) with videos related to

Sort By:
Pageof 92
JAMA Oncology|November 20, 2018
Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of MortalityDerya Tilki, Ming-Hui Chen, Jing Wu, et al.
European Urology Focus|November 21, 2017
Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European InstitutionsGiorgio Gandaglia, Derya Tilki, Emanuele Zaffuto, et al.
World Journal of Urology|March 28, 2018
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomyDerya Tilki, Felix Preisser, Pierre Karakiewicz, et al.
World Journal of Urology|April 11, 2015
Controversial evidence for the use of HistoScanning™ in the detection of prostate cancerJonas Schiffmann, Lukas Manka, Katharina Boehm, et al.
European Urology|April 19, 2017
Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation TherapyPrasanna Sooriakumaran, Tommy Nyberg, Olof Akre, et al.
Health and Quality of Life Outcomes|February 26, 2021
Health-related quality of life and self-reported cognitive function in patients with delayed neurocognitive recovery after radical prostatectomy: a prospective follow-up studyUrsula Kahl, Sarah Callsen, Stefanie Beck, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancerDirk Rades, Rudolf Schwarz, Manuel Todorovic, et al.
World Journal of Urology|January 14, 2016
Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomyBurkhard Beyer, Philipp Mandel, Uwe Michl, et al.
Asian Journal of Urology|February 5, 2024
Prevention of thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to a factor V Leiden mutation by multidisciplinary coagulation managementRandi M Pose, Sophie Knipper, Jonas Ekrutt, et al.
The Journal of Urology|March 2, 2016
Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical ProstatectomyKatharina Boehm, Alessandro Larcher, Zhe Tian, et al.
Pageof 92